Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Fujioka

Showing results (31-40 of 64) with videos related to

Pageof 7
Sort By:
The American Journal of Medicine|May 5, 2009
Obesity: why be concerned?W Virgil Brown, Ken Fujioka, Peter W F Wilson, et al.
Clinical Obesity|April 13, 2019
A call to action to inform patient-centred approaches to obesity management: Development of a disease-illness modelJohn Fastenau, Ronette L Kolotkin, Ken Fujioka, et al.
Nutrition & Diabetes|January 15, 2021
Effect of time restricted eating on body weight and fasting glucose in participants with obesity: results of a randomized, controlled, virtual clinical trialPamela M Peeke, Frank L Greenway, Sonja K Billes, et al.
Journal of Diabetes Science and Technology|July 18, 2015
Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection ExperienceKen Fujioka, Thomas Sparre, Lily Yong-Hui Sun, et al.
Tropical Medicine and Health|July 20, 2016
Genotype 1 hepatitis E virus infection with acute acalculous cholecystitis as an extrahepatic symptom: a case reportKen Fujioka, Toshiki Nishimura, Masayuki Seki, et al.
Obesity (Silver Spring, Md.)|May 8, 2021
Impact of Telemedicine During the COVID-19 Pandemic on Patient AttendanceMohini Aras, Beverly G Tchang, Andrew Crawford, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|August 11, 2016
Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of TeduglutideKen Fujioka, Khursheed Jeejeebhoy, Ulrich-Frank Pape, et al.
The Journal of Clinical Endocrinology and Metabolism|October 23, 2009
Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placeboFrank L Greenway, Eduardo Dunayevich, Gary Tollefson, et al.
Obesity Research|July 10, 2002
Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trialJames W Anderson, Frank L Greenway, Ken Fujioka, et al.
Obesity Science & Practice|January 24, 2024
Home access to a weight scale in the Hispanic/Latino population attending a community-based free clinicKen Fujioka, Jacob Fujioka, Kaley Mafong, et al.
Pageof 7

Showing results (31-40 of 64) with videos related to

Sort By:
Pageof 7
The American Journal of Medicine|May 5, 2009
Obesity: why be concerned?W Virgil Brown, Ken Fujioka, Peter W F Wilson, et al.
Clinical Obesity|April 13, 2019
A call to action to inform patient-centred approaches to obesity management: Development of a disease-illness modelJohn Fastenau, Ronette L Kolotkin, Ken Fujioka, et al.
Nutrition & Diabetes|January 15, 2021
Effect of time restricted eating on body weight and fasting glucose in participants with obesity: results of a randomized, controlled, virtual clinical trialPamela M Peeke, Frank L Greenway, Sonja K Billes, et al.
Journal of Diabetes Science and Technology|July 18, 2015
Usability of the Novel Liraglutide 3.0 mg Pen Injector Among Overweight or Obese Adult Patients With or Without Prior Injection ExperienceKen Fujioka, Thomas Sparre, Lily Yong-Hui Sun, et al.
Tropical Medicine and Health|July 20, 2016
Genotype 1 hepatitis E virus infection with acute acalculous cholecystitis as an extrahepatic symptom: a case reportKen Fujioka, Toshiki Nishimura, Masayuki Seki, et al.
Obesity (Silver Spring, Md.)|May 8, 2021
Impact of Telemedicine During the COVID-19 Pandemic on Patient AttendanceMohini Aras, Beverly G Tchang, Andrew Crawford, et al.
JPEN. Journal of Parenteral and Enteral Nutrition|August 11, 2016
Patients With Short Bowel on Narcotics During 2 Randomized Trials Have Abdominal Complaints Independent of TeduglutideKen Fujioka, Khursheed Jeejeebhoy, Ulrich-Frank Pape, et al.
The Journal of Clinical Endocrinology and Metabolism|October 23, 2009
Comparison of combined bupropion and naltrexone therapy for obesity with monotherapy and placeboFrank L Greenway, Eduardo Dunayevich, Gary Tollefson, et al.
Obesity Research|July 10, 2002
Bupropion SR enhances weight loss: a 48-week double-blind, placebo- controlled trialJames W Anderson, Frank L Greenway, Ken Fujioka, et al.
Obesity Science & Practice|January 24, 2024
Home access to a weight scale in the Hispanic/Latino population attending a community-based free clinicKen Fujioka, Jacob Fujioka, Kaley Mafong, et al.
Pageof 7